Diplomat expands infusion specialty services with acquisition of MedPro Rx Inc.
Flint, Mich.— July 18, 2014 — Diplomat, the country’s largest independent specialty pharmacy, announced today it has acquired MedPro Rx, a specialty pharmacy focused on specialty infusion therapies including hemophilia and immune globulin based in Raleigh, North Carolina.
“MedPro Rx shares our focus on caring for patients through personalized, high-touch service and communication,” said Phil Hagerman, Diplomat CEO. “We acquired MedPro to expand our existing specialty infusion business and to increase our presence in the mid-Atlantic and Southern regions of the country.”
Ron McFarlane, MedPro Rx Chief Operating Officer, is pleased to partner with Diplomat to continue MedPro Rx’s 12-year history as a provider of high-touch specialized pharmacy and infusion services.
“Diplomat’s focus on providing consistent, high-touch patient care matches our own approach for MedPro Rx patients,” said McFarlane. “We are pleased to know that the care of our patients will continue to meet the quality standards our patients know and rely on.”
MedPro Rx places a strong emphasis on patient advocacy and providing resources for patients to live at their best. “At MedPro Rx, we pride ourselves on setting the standard for specialty infusion care, incorporating personal interaction with the latest technology to provide a responsive, hassle-free experience for our patients,” said McFarlane. “Diplomat shares that vision and puts it into practice in each interaction with their own patients.”
Diplomat serves patients and physicians in all 50 states as the nation’s largest independent specialty pharmacy. Headquartered in Flint, Mich., the company focuses on medication management programs for people with specialized or long-term medical needs, including oncology, immunology, hepatitis, multiple sclerosis, HIV, infusion therapy and many other serious or chronic conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues — always focused on increasing adherence and improving outcomes. Diplomat is accredited by URAC, VAWD, ASHP and ACHC. Learn more at diplomat.is.
@PharmacDailyRT @PharmacDaily: @DiplomatRx to distribute Puma Biotechnology’s new cancer drug $DPLO https://t.co/gl0v6WURVV4 days ago
@DiplomatRxNerlynx (neratinib) tablets for HER2+ Breast Cancer in the Extended Adjuvant Setting https://t.co/vi3ACWhbfe5 days ago
@AJPB_JournalRT @AJPB_Journal: Be sure to check out our Insights page featuring videos of Cheryl Allen from @DiplomatRx discussing #RA https://t.co/qxZc…2 weeks ago
@DiplomatRxWe're with @340BCoalition this week in Washington D.C.! Come say hello.2 weeks ago
@SpecialtyPTimesRT @SpecialtyPTimes: Rheumatoid Arthritis Treatment Guidelines https://t.co/sEhe74UozC #rheumatoidarthritis @DiplomatRx3 weeks ago